Top-News

Karo Pharmaceuticals News

Aktie
WKN:  A14YW4 ISIN:  SE0007464888 US-Symbol:  KARBF
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
164,33 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 19.08.2019

Karo Pharmaceuticals News

19.04.22 - PLX
Karo Pharma Raised SEK 2.5 billion at SEK 52 per Share
(PLX AI) – Karo Pharma rights issue subscription price SEK 52 per new share, raising SEK 2.5 billion as planned. • Rights issue was fully subscribed
16.03.22 - PLX
Karo Pharma to Raise SEK 2.5 Billion at SEK 52 per Share
(PLX AI) – Karo Pharma resolves on a fully guaranteed rights issue of approximately SEK 2.5 billion. • The subscription price is SEK 52 per new share • The last day of trading in the ...
25.02.22 - PLX
Karo Pharma Q4 EBIT SEK -52.7 Million
(PLX AI) – Karo Pharma Q4 revenue SEK 762 million. • Q4 EPS SEK -0.48
28.10.21 - PLX
Karo Pharma Q3 EBIT SEK 99.5 Million
(PLX AI) – Karo Pharma Q3 revenue SEK 738.5 million. • Q3 EPS SEK 0.26
22.07.21 - PLX
Karo Pharma Q2 EBIT SEK 31 Million vs. Estimate SEK 128 Million
(PLX AI) – Karo Pharma Q2 revenue SEK 747.9 million vs. estimate SEK 792 million. • Q2 EBITDA SEK 180.7 million vs. estimate SEK 259 million • Q2 EPS SEK -0.1
01.07.21 - PR Newswire
Karo Pharma divests brand portfolio to Evolan Pharma
Karo Pharma divests brand portfolio to Evolan Pharma PR Newswire
06.05.21 - PR Newswire
Karo Pharma to sell its treasury shares
Karo Pharma to sell its treasury shares PR Newswire
28.04.21 - PR Newswire
Karo Pharma resolves on sale of own shares
Karo Pharma resolves on sale of own shares PR Newswire
21.04.21 - PR Newswire
Interim report Q1 2021
Interim report Q1 2021 PR Newswire
01.04.21 - PR Newswire
Karo Pharma completes the acquisition of the brand portfolio from Teva Pharmaceuticals
Karo Pharma completes the acquisition of the brand portfolio from Teva Pharmaceuticals PR Newswire
30.03.21 - PR Newswire
Karo Pharma publishes the 2020 annual report
Karo Pharma publishes the 2020 annual report PR Newswire
03.02.21 - PR Newswire
Karo Pharma acquires European OTC brand portfolio from Teva Pharmaceuticals
Karo Pharma acquires European OTC brand portfolio from Teva Pharmaceuticals PR Newswire
16.11.20 - PR Newswire
Karo Pharma AB divests its Hospital Supply business, Swereco AB, to J2L Holding AB
Karo Pharma AB divests its Hospital Supply business, Swereco AB, to J2L Holding AB PR Newswire
30.10.20 - PR Newswire
Karo Pharma publishes third-quarter report 2020 and resolves on sale of own shares
Karo Pharma publishes third-​quarter report 2020 and resolves on sale of own shares PR Newswire
21.07.20 - PR Newswire
Karo Pharma: Second-quarter report 2020
Karo Pharma: Second-​quarter report 2020 PR Newswire
25.05.20 - PR Newswire
Annual General Meeting 2020 in Karo Pharma Aktiebolag
Annual General Meeting 2020 in Karo Pharma Aktiebolag PR Newswire
08.05.20 - PR Newswire
Karo Pharma Acquires Pevaryl® Brand Portfolio From Cilag GmbH International, an Affiliate of Johnson & Johnson
Karo Pharma Acquires Pevaryl® Brand Portfolio From Cilag GmbH International, an Affiliate of Johnson & Johnson PR Newswire
29.04.20 - PR Newswire
Karo Pharma: Interim report Q1 2020
Karo Pharma: Interim report Q1 2020 PR Newswire
01.04.20 - PR Newswire
Karo Pharma Enters the Swiss Market with Direct Presence by Acquiring Hygis SA
Karo Pharma Enters the Swiss Market with Direct Presence by Acquiring Hygis SA PR Newswire
01.04.20 - PR Newswire
Karo Pharma Publishes the 2019 Annual Report
Karo Pharma Publishes the 2019 Annual Report PR Newswire

Newssuche

Videos

newspaper
03.05.24 -13,45%
Technical Trading: Gold freitags Long
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »